Spotlight On... Allergan ushers #ActuallySheCan campaign onto Tribeca festival screens; J&J beefs up in Africa to drive new growth; Hedge funder takes a $258M hit on merger collapse; and more...

Allergan ($AGN) is taking its hashtag-heavy, emoji-laden female empowerment campaign, #ActuallySheCan, to the Tribeca Film Festival. Three women directors created films featuring three women aiming at big goals, including one who's competing in the famed Iditarod sled-dog race. All three will be screened at the New York-based festival. More from FiercePharmaMarketing

@FiercePharma: WHO fights Angola yellow fever outbreak, global vaccine shortage. More from FierceVaccines | Follow @FiercePharma

@EricPFierce: Unable to find a buyer, Sun will close the Ranbaxy plant in Ireland, lay off 70 remaining workers. FiercePharmaManufacturing report | Follow @EricPFierce

@CarlyHFierce: Valeant's prized GI force, once shielded from job cuts, faces the ax. FiercePharmaMarketing story | Follow @CarlyHFierce

> Johnson & Johnson ($JNJ) is eyeing more growth in Africa, and it's adding new R&D and distribution there to beef up sales of new meds to fight HIV and other diseases common on the continent. Report

> Hedge fund billionaire John Paulson may have suffered a $258 million hit on the collapse of the Pfizer-Allergan merger, harking back to previous losses from a bet on the AbbVie-Shire combo, which also failed because of tax-inversion rule changes. Report

> Amphastar Pharmaceuticals ($AMPH), which has come in for criticism for the price of its overdose antidote naloxone, agreed to give Connecticut a $6 rebate for each dose purchased by a state or municipal agency. Report

> The cost of insulin treatments for diabetes rose by nearly 200% from 2002 to 2013, the Journal of the American Medical Association reports, as expensive new analog treatments supplanted older human insulins. Report

> Hedge funder Bill Ackman is set to explain a 25% quarterly loss to his investors Wednesday, with his bad bet on Valeant Pharmaceuticals ($VRX) first in line. Report

Medical Device News

@FierceMedDev: ICYMI yesterday: Warburg-backed Sterigenics buys Nelson Labs to create largest sterilization, testing firm. Article | Follow @FierceMedDev

@EmilyWFierce: ICYMI from FiercePharma: Biogen, Samsung accuse AbbVie of evergreening Humira patents to block biosims. Report | Follow @EmilyWFierce

> Duke University sends recs to FDA for new medical device safety evaluation system. Article

Biotech News

@FierceBiotech: New study highlights a gut pathway for red wine compound resveratrol. More from FierceBiotechResearch | Follow @FierceBiotech

@JohnCFierce: Allergan pivots back to dealmaking as analysts link Pfizer to AbbVie, Biogen and Regeneron. Story | Follow @JohnCFierce

> J&J grabs prostate cancer rights for Tesaro's niraparib in $500M deal. Report

> Apricus wields ax to its pipeline, staff after key testosterone drug fails. Story

> Celltrion, Pfizer win landmark FDA OK for a biosimilar of J&J's blockbuster Remicade. Article

Biotech Research News

> Wistar scientists show impact of aging on melanoma therapy in the lab. Report

> U.S. academics test new mouse model for possible Zika vaccine. More

> Cryoablation therapy used to treat phantom limb pain. Item

> New study highlights a gut pathway for red wine compound resveratrol. Story

> A stem cell therapy trial finally delivers positive results for heart failure. Article

Vaccines News

> Complacency could derail Ebola progress, experts warn. Item

> Experts share info in scramble to fight 'impressive' Zika virus. Report

> WHO fights Angola yellow fever outbreak, global vaccine shortage. Story

> NIAID greenlights funds for adjuvant research. Article

> Genocea reports promising 12-month data for its genital herpes vaccine. More

Pharma Marketing News

> Up up and away: 2015 pharma ad spending ties decade-old record. Item

> Allergan amps up #ActuallySheCan campaign with Tribeca festival film. More

> Boomers are tough on digital pharma ads, but they do like celeb endorsements. Report

> Valeant's prized GI force, once shielded from job cuts, faces the ax. Story

> FDA nitpicks Shiongi's head lice copay voucher over 'false and misleading' claims. Article

And Finally... Worldwide diabetes cases hit 422 million as the disease mushrooms in the developing world. Report